Observational studyInternational journal of clinical pharmacy2021

Study comparing the efficacy and renal safety for patients with diabetes switching from dapagliflozin to empagliflozin.

Ai-Yu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.